NIH-funded research R21 grant

Optogenetic control of bacterial persistence to study biomaterial infections

Funded at University of Tennessee Knoxville · NIH-11482135 · Data updated 2026-11-12

A small NIH grant aims to use blue light to turn on a bacterial persistence mechanism in a lab model, helping us understand and fight infections on medical devices.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Tennessee Knoxville
NIH-funded
Lab location1 site (Knoxville, United States)
Project startJune 6, 2024
Project endMay 31, 2027
Funding year2025
Award (this year)$152,579
NIH project number7R21AI185651-03
Project IDNIH-11482135 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable for direct participation; the study is in basic research using engineered bacteria and animal models.

Less likely to help

No direct patient participation or immediate clinical testing is planned.

What this research studies

This project uses a specially engineered E. coli to trigger a persistence pathway with blue light, creating an in vivo model to study how persister cells survive antibiotics. The goal is to observe how persister cells form and how they can be controlled in the context of biomaterial-associated infections. By developing an animal-relevant model, researchers hope to test new antimicrobials and biomaterials that could reduce chronic infections.

Why it matters

Potential benefit: If successful, this work could lead to new strategies to prevent or treat infections on medical devices by targeting persister cells.

How similar studies have gone: Other persister cell studies have shown the importance of understanding persistence, but an in vivo optogenetic model for persuasion is a novel approach.

Where this research is happening

  • University of Tennessee Knoxville
    Knoxville, United States
    Active

Researchers

  • Principal investigator: Ren, Dacheng — University of Tennessee Knoxville
  • Study coordinator: Ren, Dacheng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.